A. Pelegrí

Randomized Phase 3 Trial of Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer

Miguel Martín, Álvaro Rodríguez-Lescure, A. Ruiz et al. · JNCI Journal of the National Cancer Institute · 2008 · 238 citations · Full text

Epirubicin–cyclophosphamide adjuvant chemotherapy plus tamoxifen administered concurrently versus sequentially: randomized phase III trial in postmenopausal node-positive breast cancer patients. A GEICAM 9401 study

Cesar Pico, Miguel Martín, Carlos Jara et al. · Annals of Oncology · 2003 · 84 citations · Full text

Blood Pressure After Recent Stroke: Baseline Findings From the Secondary Prevention of Small Subcortical Strokes Trial

Carole L. White, Pablo E. Pérgola, Jeff M. Szychowski et al. · American Journal of Hypertension · 2013 · 54 citations · Full text

Prognostic value of apoptosis in breast cancer (pT1-pT2). A TUNEL, p53, bcl-2, bag-1 and Bax immunohistochemical study.

Juan J. Sirvent, Mariela C Aguilar, Montserrat Olona et al. · PubMed · 2004 · 34 citations

Breast Oncology, Tunel Method, Apoptosis +16

Docetaxel/Gemcitabine Administered Every Other Week as First-Line Treatment for Metastatic Breast Cancer: Final Results of a Phase II Trial

A. Pelegrí, Lourdes Calvo, Antonio Antón et al. · Clinical Breast Cancer · 2005 · 22 citations

Metastatic Breast Cancer, Oncology, Breast Oncology +8